CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification

Area of Science:

• Genomic research
• Parasitology
• Molecular biology

Background:

• Malaria, caused by Plasmodium parasites, remains a significant global health challenge.
• Genomic editing is crucial for understanding Plasmodium biology, identifying therapeutic targets, and developing diagnostics.
• Current RNA-level manipulation tools in Plasmodium are hindered by the parasite's weak RNA interference (RNAi) machinery.

Purpose of the Study:

• To review the CRISPR-Cas13 system, including its discovery, classification, and mechanism of action.
• To explore the diagnostic platforms utilizing CRISPR-Cas13.
• To discuss the potential applications, advantages, and disadvantages of Cas13-based systems for Plasmodium research.

Main Methods:

• Review of scientific literature on CRISPR-Cas13.
• Analysis of CRISPR-Cas13's mechanism for RNA binding and cleavage.
• Evaluation of CRISPR-Cas13's suitability for Plasmodium genetic manipulation and diagnostics.

Main Results:

• CRISPR-Cas13, a type VI CRISPR system, precisely targets and cleaves RNA guided by CRISPR RNA (crRNA).
• Cas13 offers RNA editing with minimal permanent genetic alterations.
• CRISPR-Cas13-based diagnostic platforms have been developed.

Conclusions:

• CRISPR-Cas13 presents a powerful and versatile tool for RNA manipulation in Plasmodium.
• This technology can overcome the limitations of Plasmodium's endogenous RNAi system.
• Cas13-based systems hold significant promise for advancing malaria research, diagnostics, and therapeutic development.